DAVIS DOUGLAS LEE 4

What Happened

• Douglas L. Davis, a member of Cerence Inc.'s Board of Directors, was granted 12,968 restricted stock units (RSUs) on February 12, 2026. The Form 4 reports a nominal acquisition price of $0.01 per share (total reported value $130). This was an award/grant (transaction code A), a form of equity compensation—not an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-12; Form 4 filed: 2026-02-13 (timely filing).
• Award: 12,968 RSUs at $0.01 per share; aggregate reported value $130.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote (F1): RSUs vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately prior to the company’s next fiscal year Annual General Meeting.
• No 10b5-1 plan, tax-withholding sale, or gift noted in the provided details.

Context

• RSU grants are common director compensation/retention tools and do not involve an immediate cash purchase or sale of shares. They convert into actual shares only upon vesting, so this grant alone is not a direct market signal to buy or sell Cerence stock.